Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	-	-	-	-	24.74	16.23
Other Revenue	16.34	11.98	7.89	2.5	0.07	-
Revenue	16.34	11.98	7.89	2.5	24.81	16.23
Revenue Growth (YoY)	6.26%	51.78%	215.26%	-89.91%	52.90%	-
Cost of Revenue	-	-	-	-	20.15	14.81
Gross Profit	16.34	11.98	7.89	2.5	4.66	1.42
Selling, General & Admin	2.17	1.68	0.84	1.75	0.54	0.14
Other Operating Expenses	10.44	13	3.67	2.72	1.08	1.23
Operating Expenses	12.62	14.68	4.51	4.46	1.62	1.37
Operating Income	3.72	-2.7	3.38	-1.96	3.04	0.05
Other Non Operating Income (Expenses)	8.39	-	-	-	-	-0
EBT Excluding Unusual Items	12.1	-2.7	3.38	-1.96	3.04	0.05
Gain (Loss) on Sale of Investments	-	-	-	-	-3.12	-16.08
Gain (Loss) on Sale of Assets	-	-	15.92	6.63	-	-
Pretax Income	12.1	-2.7	19.31	4.67	-0.09	-16.03
Income Tax Expense	-	0.23	-	0.11	-	-
Net Income	12.1	-2.93	19.31	4.56	-0.09	-16.03
Net Income to Common	12.1	-2.93	19.31	4.56	-0.09	-16.03
Net Income Growth	-11.37%	-	323.86%	-	-	-
Shares Outstanding (Basic)	1,345	653	653	653	653	653
Shares Outstanding (Diluted)	1,345	653	653	653	653	653
EPS (Basic)	0.01	-0.00	0.03	0.01	-0.00	-0.02
EPS (Diluted)	0.01	-0.00	0.03	0.01	-0.00	-0.02
EPS Growth	-	-	323.90%	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	18.79%	8.75%
Operating Margin	22.76%	-22.54%	42.87%	-78.19%	12.24%	0.31%
Profit Margin	74.09%	-24.44%	244.67%	181.98%	-0.35%	-98.80%
EBIT	3.72	-2.7	3.38	-1.96	3.04	0.05
EBIT Margin	22.76%	-22.54%	42.87%	-78.19%	12.24%	0.31%
Effective Tax Rate	-	-	-	2.42%	-	-
Revenue as Reported	24.72	11.98	23.82	9.13	24.81	16.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.